Data as of Aug 22
| 0.00 / 0.00%|
The 1 analysts offering 12-month price forecasts for Medgenics Inc have a median target of 9.83, with a high estimate of 9.83 and a low estimate of 9.83. The median estimate represents a +56.00% increase from the last price of 6.30.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.